Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq
NEW YORK, January 8, 2026, 13:45 EST — Regular session Regencell Bioscience Holdings Limited shares were down 18.5% at $43.10 on Thursday, a sharp reversal after an early spike that pushed the Nasdaq-listed stock as high as $69.97. The shares